Tag Archives: AnaptysBio stock

AnaptysBio’s Spinoff Is Done. Is ANAB or TRAX the Better Bet?

By |
2 Comments

AnaptysBio(ANAB) completed the spinoff of First Tracks Biotherapeutics (TRAX) on April 20. We wrote about the planned separation back in October, when the announcement sent AnaptysBio shares up more than 30%. Then the spinoff happened, First Tracks started trading, and we haven’t gotten around to discussing it now. Hopefully, we will have a lot of late posts coming… Read More »

AnaptysBio Spinoff News Sends Stock Up More Than 30%

By |
1 Comment

AnaptysBio (ANAB) announced on Monday, September 29, 2025 that it plans to spinoff its biopharma programs from its royalty and milestone assets by the end of 2026. Investors cheered the move: AnaptysBio stock is up more than 30% to around $31.75 on heavy volume. According to the press release, the transaction would create two independent companies: A royalty… Read More »